COLLEEN HARRISON: Open Payments
NPI 1447439120 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 18 payments from 12 companies in 2025. Trend: 2023 $609 · 2024 $938 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| PFIZER INC. | 3 | $71 |
| ABBVIE INC. | 3 | $69 |
| Supernus Pharmaceuticals, Inc. | 1 | $43 |
| UCB, Inc. | 1 | $38 |
| LivaNova USA, Inc. | 1 | $38 |
| MDD US Operations, LLC | 1 | $32 |
| Celgene Corporation | 1 | $31 |
| Impel Pharmaceuticals LLC | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
Products named: AUSTEDO XR, NURTEC ODT, QULIPTA, Qelbree, Briviact, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Gocovri, ZEPOSIA.
Industry payments across IL — which companies pay providers there.
